Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Associations of the gut microbiome with outcomes in cervical and endometrial cancer patients treated with pembrolizumab: Insights from the phase II PRIMMO trial.
De Jaeghere EA, Hamerlinck H, Tuyaerts S, Lippens L, Van Nuffel AMT, Baiden-Amissah R, Vuylsteke P, Henry S, Trinh XB, van Dam PA, Aspeslagh S, De Caluwé A, Naert E, Lambrechts D, Hendrix A, De Wever O, Van de Vijver KK, Amant F, Vandecasteele K, Verhasselt B, Denys HG. De Jaeghere EA, et al. Gynecol Oncol. 2024 Dec;191:275-286. doi: 10.1016/j.ygyno.2024.10.020. Epub 2024 Nov 7. Gynecol Oncol. 2024. PMID: 39515198 Clinical Trial.
Sexual health in Belgian cervical cancer survivors: an exploratory qualitative study.
Naert E, Van Hulle H, De Jaeghere EA, Orije MRP, Roels S, Salihi R, Traen KJ, Watty K, Kinnaer LM, Verstraelen H, Tummers P, Vandecasteele K, Denys HG. Naert E, et al. Among authors: de jaeghere ea. Qual Life Res. 2024 May;33(5):1401-1414. doi: 10.1007/s11136-024-03603-5. Epub 2024 Feb 24. Qual Life Res. 2024. PMID: 38396183
Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study.
De Jaeghere EA, Tuyaerts S, Van Nuffel AMT, Belmans A, Bogaerts K, Baiden-Amissah R, Lippens L, Vuylsteke P, Henry S, Trinh XB, van Dam PA, Aspeslagh S, De Caluwé A, Naert E, Lambrechts D, Hendrix A, De Wever O, Van de Vijver KK, Amant F, Vandecasteele K, Denys HG. De Jaeghere EA, et al. Cancer Immunol Immunother. 2023 Feb;72(2):475-491. doi: 10.1007/s00262-022-03253-x. Epub 2022 Aug 12. Cancer Immunol Immunother. 2023. PMID: 35960332 Free PMC article. Clinical Trial.
Mental Health and Quality of Life among Patients with Cancer during the SARS-CoV-2 Pandemic: Results from the Longitudinal ONCOVID Survey Study.
De Jaeghere EA, Kanervo H, Colman R, Schrauwen W, West P, Vandemaele N, De Pauw A, Jacobs C, Hilderson I, Saerens M, Sundahl N, Vandecasteele K, Naert E, Lapeire L, Kruse V, Rottey S, Lemmens G, Denys HG. De Jaeghere EA, et al. Cancers (Basel). 2022 Feb 21;14(4):1093. doi: 10.3390/cancers14041093. Cancers (Basel). 2022. PMID: 35205838 Free PMC article.
Splenic Hematopoietic and Stromal Cells in Cancer Progression.
Steenbrugge J, De Jaeghere EA, Meyer E, Denys H, De Wever O. Steenbrugge J, et al. Among authors: de jaeghere ea. Cancer Res. 2021 Jan 1;81(1):27-34. doi: 10.1158/0008-5472.CAN-20-2339. Epub 2020 Sep 30. Cancer Res. 2021. PMID: 32998999 Review.
Splenic 18F-FDG uptake on baseline PET/CT is associated with oncological outcomes and tumor immune state in uterine cervical cancer.
De Jaeghere EA, Laloo F, Lippens L, Van Bockstal M, De Man K, Naert E, Van Dorpe J, Van de Vijver K, Tummers P, Makar A, De Visschere PJL, De Wever O, Amant F, Denys HG, Vandecasteele K. De Jaeghere EA, et al. Gynecol Oncol. 2020 Nov;159(2):335-343. doi: 10.1016/j.ygyno.2020.08.001. Epub 2020 Aug 25. Gynecol Oncol. 2020. PMID: 32859399
14 results